Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ear seeds could help psychiatric patients kick smoking withdrawal symptoms

NCT ID NCT07466875

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether adding ear acupressure (small seeds taped to ear points) to standard nicotine patches or gum can reduce cravings, withdrawal symptoms, and anxiety in psychiatric inpatients who must stop smoking during their hospital stay. Sixty participants will be randomly assigned to receive either real ear seeds or sham seeds for 28 days. Researchers will measure changes in craving, withdrawal severity, and anxiety levels to see if the ear stimulation provides extra relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
auricular acupressure (ear seeds) plus nicotine replacement therapy (patches or gum)
What this could lead to
If it works, this could offer a simple, low-cost add-on to help psychiatric patients manage nicotine withdrawal and anxiety during hospital stays.
What could go wrong
This is a small pilot study (60 people) testing feasibility, not proof of effectiveness. The sham control group may also show benefits, and results may not apply to non-psychiatric or outpatient settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Psychiatric inpatients aged 18 to 65 years. * Diagnosed with a mental disorder according to ICD-10-CM criteria. * History of daily smoking within the past six months (Fagerström Test for Nicotine Dependence \[FTND\] score ≥ 2). * Experiencing nicotine withdrawal symptoms due to mandatory smoking cessation upon admission (Minnesota Tobacco Withdrawal Scale \[MNWS\] baseline score ≥ 5). * Agree to and comply with the standard-of-care Nicotine Replacement Therapy (NRT) provided by the hospital. * Capable of understanding the study procedures and providing written informed consent Exclusion Criteria: * Presence of severe skin infection, open wounds, or lesions on the auricle (outer ear). * Severe coagulation disorders or currently taking high-dose anticoagulants (due to potential risk of bleeding or irritation). * Pregnant or breastfeeding women. * Significant language barriers or cognitive impairment that prevents completion of assessment scales or adherence to study protocols. * History of receiving auricular therapy for smoking cessation within the past three months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Tsaotun Psychiatric Center, Ministry of Health and Welfare

    RECRUITING

    Nantou City, 542, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.